Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine blood level-guided dosing to reduce systemic lupus erythematosus flares
2006-003025-93Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydroxychloroquine in systemic lupus erythematosus (SLE) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2007; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on 2006-003025-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003025-93.